Fairfax Media network navigation

  • Home
  • Shares
  • Share details

IMUGENE LIMITED (IMU)


Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Imugene Limited
Stock Code: IMU
Website: www.imugene.com
GICS Sub-Industry: Biotechnology
Market Cap ($M): 1
Equiv. Shares (M): 242

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.006 $ 0.000 $ 0.000 $ 0.000 $ 0.006 0 0%

Current Broker Consensus Recommendation more
Recommendation: Sell
Recommendation Date: 19th Dec 2008
12 Month Target Price (average): $0
Brokers Surveyed: 1

Company Overview

Business Description:
Imugene Limited (IMU) is commercialising drug delivery applications based on its novel buccal (drugs administered via the cheek) Linguet technology, using to established pharmaceutical and nutraceutical products. IMU also currently specialises in the development and commercialisation of novel animal health products for pigs and poultry.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2012  A -1.0 -0.7 -333.3 0.0 0.0 0.0 --
2011  A 0.4 0.3 -- 19.0 0.0 0.0 --
2010  A -1.5 -1.1 -375.0 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F
CSL (CSL) $30,048 M 0.0878 0.2981 0.1366 32.2266 24.8256 21.8418 0.0136 0.0173 0.0195
Imugene (IMU) $1 M -- -- -- -- -- -- 0.0000 -- --
Mesoblast (MSB) $1,902 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Starpharma (SPL) $245 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Sirtex Medical (SRX) $598 M 0.4803 0.9033 0.3573 35.4967 18.6500 13.7401 0.0093 0.0179 0.0238

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
IMU -- -- 0.80 -- 3.75
Market 1.08 12.7 0.89 1.87 2.60
Sector 0.91 20.0 2.40 0.54 6.80

Directors
Name Position Start Date
Mr Justyn Stedwell Company Secretary 30 July 2012
Dr Nicholas Ede Executive Director 11 February 2013
Mr Paul Hopper Non-Executive Director 31 October 2012
Mr Steve Harris Non-Executive Director,Non-Executive Chairman 01 August 2012

Management
Name Position
Michael Sheppard Chief Scientific Officer
Phillip Hains Joint Company Secretary

Substantial Shareholders
Holding Name
100,000,000 (29.10%) Consegna Group Ltd

Calendar of Events
Date Event
27 February 2014 Report (Interim)
28 October 2013 Report (Annual)
30 August 2013 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investing in Property through Super

An educational booklet on running your own superannuation fund and investing in property.

More details...

News

Grim reflections: the slow death of an industry

The Age 25/05/2013 | In the mid-1960s, when Australia's trade minister Sir John McEwen was urging Holden and Ford to seek export markets in Asia, the leader of one of Asia's poorest countries decided his country needed a car industry.

Buildplan creditors hurting

The Age 25/05/2013 | Debts to tradespeople and suppliers by collapsed builder National Buildplan Group have blown out to $58 million but administrators say they are likely to recoup only cents in the dollar.

In the big picture, luck, tax cuts tell true deficit story

The Age 25/05/2013 | They say it's only when the tide goes out you discover who's been swimming naked.

Big spenders go for Coffey

The Age 25/05/2013 | Beaten-down stocks linked to the resource sector featured on the directors' trades front this week.

Bernanke all talk, no action (yet), on stimulus

The Age 25/05/2013 | There's a simple message in what appeared to be conflicting statements from the Federal Reserve, its chairman, Ben Bernanke, and an assortment of other Fed heavies this week about the timing of a move to re-tighten monetary policy.

Markets, investors on edge as Fed prepares to shift gears

The Age 25/05/2013 | Investors are contemplating a future without support from one of the biggest drivers of the global economy in recent years - the US Federal Reserve.

More...

Sponsored Links
Feedback Form